Lv3
210 积分 2023-09-11 加入
Recalcitrant lichen planopilaris treated with upadacitinib: a case series
6天前
已完结
Upadacitinib for refractory alopecia areata unresponsive to prior systemic therapies: A retrospective study
6天前
已完结
Effects of Vunakizumab Treatment on Detailed Dimensions of Patient-Reported Outcomes in Moderate-to-Severe Plaque Psoriasis Patients: A Post-Hoc Analysis of a Randomized Controlled Trial (NCT04839016)
11天前
已完结
Guidelines for diagnosis, prevention, and treatment of hand eczema
1个月前
已完结
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
1个月前
已完结
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
1个月前
已完结
Acupuncture for Melasma in Women: A Systematic Review of Randomised Controlled Trials
2个月前
已完结
Efficacy, Safety, and Early Relapse After Cessation of Upadacitinib Versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis®: A Real-World Study in China
2个月前
已完结
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
3个月前
已完结
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
3个月前
已完结
皖公网安备34019202002308